Results 151 to 160 of about 10,365,683 (253)

Potential impact of epicardial fat thickness, pentraxin-3, and high-sensitive C-reactive protein on the risk of non-proliferative diabetic retinopathy. [PDF]

J Diabetes Metab Disord, 2023
Gameil MA, Elsherbiny HA, Youssry IE, Gawad SA, Arafat AAE.   +4 more
europepmc   +1 more source

Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling

Comprehensive Physiology, Volume 16, Issue 5, October 2026.
Short‐chain fatty acids generated by gut microbial fermentation link diet to ocular physiology via the gut–eye axis. Through systemic distribution, these metabolites regulate GPCR signaling, epigenetic pathways, inflammation, and angiogenesis, shaping retinal homeostasis and highlighting therapeutic potential in ocular vascular and inflammatory ...
Aleah J. Brokemond, Ronny Amamoo, Fapianey J. Alexandre, Sewedo B. Ajisegiri, Menaka C. Thounaojam, Pamela M. Martin, Ravirajsinh N. Jadeja   +6 more
wiley   +1 more source

Prevalence of diabetic retinopathy at Parirenyatwa hospital

, 2016
BACKGROUND: There is a global epidemic of diabetes mellitus. Diabetes mellitus causes a myriad of microvascular and macrovascular complications. Diabetic retinopathy is one of the main microvascular complications. It is preventable.
Maboreke, Nyasha Phanuel
core  

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift? [PDF]

J Ophthalmic Vis Res, 2022
Arabi A, Tadayoni R, Ahmadieh H, Shahraki T, Nikkhah H.   +4 more
europepmc   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Association of systemic inflammatory indices and body mass index with diabetic macular edema in non-proliferative diabetic retinopathy. [PDF]

BMC Ophthalmol
Harley O, Amelia YS, Gustianty E, Soetedjo NNM, Kartasasmita AS.   +4 more
europepmc   +1 more source

Reproducibility of macular perfusion parameters in non-proliferative diabetic retinopathy patients by two different OCTA sweep modes. [PDF]

Int J Ophthalmol, 2022
Qu S, Rong A, Niu YL, Liu X, Zhang YS, Liu CY, Bi YL.   +6 more
europepmc   +1 more source

Associations Between Antidiabetic Pharmacotherapy and Hearing Thresholds in Adult Hearing‐Impaired Patients With Type 2 Diabetes

Pharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
ABSTRACT Type 2 diabetes mellitus (T2DM) has increasingly been identified as a risk factor for sensorineural hearing loss, whereas the association between different antidiabetic therapies and hearing thresholds remains poorly characterized. This retrospective observational study evaluated 240 patients with T2DM and 105 normoglycemic controls who ...
Francesco Martines, Pietro Salvago, Francesca Vaccaro, Davide Vaccaro, Ginevra Malta, Fabiana Plescia, Stella Cascioferro, Gianluca Lavanco, Fulvio Plescia   +8 more
wiley   +1 more source

Application of construction and validation of logistic regression model in risk prediction of non-proliferative diabetic retinopathy in type 2 diabetes mellitus. [PDF]

Diabet Med
Zhang J, Cao X, Yu X, Jiang M, Xie T, Wang Y, Tang Z.   +6 more
europepmc   +1 more source

The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials. [PDF]

Front Endocrinol (Lausanne), 2023
Liu Z, Chen Y, Jie C, Wang J, Deng Y, Hou X, Li Y, Cai W.   +7 more
europepmc   +1 more source